Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade

被引:95
作者
Harir, Noria [2 ]
Boudot, Cedric [2 ]
Friedbichler, Katrin [1 ]
Sonneck, Karoline [3 ]
Kondo, Rudin [3 ]
Martin-Lanneree, Severine [4 ,5 ]
Kenner, Lukas [1 ,6 ]
Kerenyi, Marc [7 ]
Yahiaoui, Saliha [2 ]
Gouilleux-Gruart, Valerie [2 ]
Gondry, Jean [8 ]
Benit, Laurence [4 ,5 ]
Dusanter-Fourt, Isabelle [4 ,5 ]
Lassoued, Kaiss [2 ]
Valent, Peter [3 ]
Moriggl, Richard [1 ]
Gouilleux, Fabrice [2 ]
机构
[1] Ludwig Boltzmann Inst Canc Res, A-1090 Vienna, Austria
[2] Univ Picardie J Verne, Fac Med, INSERM, EMI 351, Amiens, France
[3] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria
[4] Univ Paris 05, Inst Cochin Genet Mol, CNRS, UMR 8104, Paris, France
[5] INSERM, U567, Paris, France
[6] Med Univ Vienna, Dept Pathol, Vienna, Austria
[7] Med Univ Vienna, Div Mol Biol, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria
[8] Ctr Hosp Univ, Ctr Gynecol Obstet, Amiens, France
基金
奥地利科学基金会;
关键词
D O I
10.1182/blood-2007-09-115477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The D816V-mutated variant of Kit triggers multiple signaling pathways and is considered essential for malignant transformation in mast cell (MC) neoplasms. We here describe that constitutive activation of the Stat5-PI3K-Akt-cascade controls neoplastic MC development. Retrovirally transduced active Stat5 (cS5F) was found to trigger PI3K and Akt activation, and to transform murine bone marrow progenitors into tissue-infiltrating MCs. Primary neoplastic Kit D816V(+) MCs in patients with mastocytosis also displayed activated Stat5, which was found to localize to the cytoplasm and to form a signaling complex with PI3K, with consecutive Akt activation. Finally, the knock-down of either Stat5 or Akt activity resulted in growth inhibition of neoplastic Kit D816V(+) MCs. These data suggest that a downstream Stat5-PI3K-Akt signaling cascade is essential for Kit D816V-mediated growth and survival of neoplastic MCs.
引用
收藏
页码:2463 / 2473
页数:11
相关论文
共 50 条
  • [21] Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3-and KIT-Driven Leukemogenesis
    Chatterjee, Anindya
    Ghosh, Joydeep
    Ramdas, Baskar
    Mali, Raghuveer Singh
    Martin, Holly
    Kobayashi, Michihiro
    Vemula, Sasidhar
    Canela, Victor H.
    Waskow, Emily R.
    Visconte, Valeria
    Tiu, Ramon V.
    Smith, Catherine C.
    Shah, Neil
    Bunting, Kevin D.
    Boswell, H. Scott
    Liu, Yan
    Chan, Rebecca J.
    Kapur, Reuben
    CELL REPORTS, 2014, 9 (04): : 1333 - 1348
  • [22] Detection of activated STAT5 in neoplastic mast cells in patients with systemic mastocytosis: Role of c-kit D816V
    Sonneck, K
    Mayerhofer, M
    Gleixner, KV
    Kerenyi, M
    Krauth, MT
    Fritz, R
    Sillaber, C
    Moriggl, R
    Valent, P
    BLOOD, 2005, 106 (11) : 981A - 981A
  • [23] STAT3/STAT5 BALANCE AS A BIOMARKER IN RA: CTLA4-IG AND T CELL DIFFERENTIATION THROUGH STAT SIGNALING
    Alivernini, Stefano
    Tolusso, Barbara
    Fedele, Anna Laura
    Di Mario, Clara
    Petricca, Luca
    Gigante, Maria Rita
    Ferraccioli, Gianfranco
    Gremese, Elisa
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1100 - 1100
  • [24] Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling
    Hayashi, Hideko
    Tsuchiya, Yoshiki
    Nakayama, Kei
    Satoh, Takayuki
    Nishida, Eisuke
    GENES TO CELLS, 2008, 13 (09) : 941 - 947
  • [25] PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
    I. Garces de los Fayos Alonso
    L. Zujo
    I. Wiest
    P. Kodajova
    G. Timelthaler
    S. Edtmayer
    M. Zrimšek
    S. Kollmann
    C. Giordano
    M. Kothmayer
    H. A. Neubauer
    S. Dey
    M. Schlederer
    B. S. Schmalzbauer
    T. Limberger
    C. Probst
    O. Pusch
    S. Högler
    S. Tangermann
    O. Merkel
    A. I. Schiefer
    C. Kornauth
    N. Prutsch
    M. Zimmerman
    B. Abraham
    J. Anagnostopoulos
    L. Quintanilla-Martinez
    S. Mathas
    P. Wolf
    D. Stoiber
    P. B. Staber
    G. Egger
    W. Klapper
    W. Woessmann
    T. A. Look
    P. Gunning
    S. D. Turner
    R. Moriggl
    S. Lagger
    L. Kenner
    Molecular Cancer, 21
  • [26] PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
    Alonso, I. Garces de los Fayos
    Zujo, L.
    Wiest, I
    Kodajova, P.
    Timelthaler, G.
    Edtmayer, S.
    Zrimsek, M.
    Kollmann, S.
    Giordano, C.
    Kothmayer, M.
    Neubauer, H. A.
    Dey, S.
    Schlederer, M.
    Schmalzbauer, B. S.
    Limberger, T.
    Probst, C.
    Pusch, O.
    Hogler, S.
    Tangermann, S.
    Merkel, O.
    Schiefer, A., I
    Kornauth, C.
    Prutsch, N.
    Zimmerman, M.
    Abraham, B.
    Anagnostopoulos, J.
    Quintanilla-Martinez, L.
    Mathas, S.
    Wolf, P.
    Stoiber, D.
    Staber, P. B.
    Egger, G.
    Klapper, W.
    Woessmann, W.
    Look, T. A.
    Gunning, P.
    Turner, S. D.
    Moriggl, R.
    Lagger, S.
    Kenner, L.
    MOLECULAR CANCER, 2022, 21 (01)
  • [27] The receptor tyrosine kinase Kit signaling through phosphatidylinositol (PI) 3-kinase stimulates mouse Leydig cell steroidogenesis.
    Rothschild, G
    Sottas, CM
    Kissel, H
    Hardy, MP
    Besmer, P
    BIOLOGY OF REPRODUCTION, 2001, 64 : 210 - 210
  • [28] Interleukin-5 suppresses Vascular Endothelial Growth Factor -induced angiogenesis through STAT5 signaling
    Bucher, Felicitas
    Lee, Jungho
    Shin, Sanghee
    Kim, Minseok S.
    Oh, Yong-Seok
    Ha, Sanghoon
    Zhang, Hongkai
    Yea, Kyungmoo
    CYTOKINE, 2018, 110 : 397 - 403
  • [29] Endomembrane HRas controls the PI3 kinase/Akt/eNOS signaling cascade in VEGF induced endothelial cell migration
    Haeussler, Dagmar
    Burgoyne, Joseph R.
    Hou, Xiuyun
    Pimental, David R.
    Cohen, Richard A.
    Bachschmid, Markus M.
    FASEB JOURNAL, 2013, 27
  • [30] Endomembrane HRas Controls the PI3 Kinase/Akt/eNOS Signaling Cascade in VEGF Induced Endothelial Cell Migration
    Haeussler, Dagmar J.
    Pimentel, David R.
    Hou, Xiuyun
    Burgoyne, Joseph R.
    Cohen, Richard A.
    Bachschmid, Markus M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 : S31 - S31